Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03669133 · ClinicalTrials.gov registry record · Phase 2
Vitamin E for NASH Treatment in HIV Infected Individuals
A Phase 2 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT03669133 is a Phase 2 study that was terminated before completion, run by Indiana University. The registered enrollment target is 3 participants.
The verdict
NCT03669133, a Phase 2 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to see how taking Vitamin E daily affects fatty liver in persons living with HIV. Subjects will have both HIV and a fatty liver and the purpose of the study is to learn if underlying liver condition (fatty liver) gets better, worse, or stays the same from taking Vitamin E.
Interventions
- DRUG Placebo
- DRUG Vitamin E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2021-03-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03669133
The ClinicalTrials.gov registry entry for NCT03669133 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03669133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03669133 about?
NCT03669133 is a clinical study titled "Vitamin E for NASH Treatment in HIV Infected Individuals". The purpose of this study is to see how taking Vitamin E daily affects fatty liver in persons living with HIV. Subjects will have both HIV and a fatty liver and the purpose of the study is to learn if underlying liver condition (fatty liver) gets better, worse, or stays the same from taking Vitamin ...
What is the current status of trial NCT03669133?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2019-10-01. Estimated completion is 2021-03-08.
What interventions are being tested in trial NCT03669133?
The interventions under investigation include: Placebo (DRUG), Vitamin E (DRUG).
Who is sponsoring clinical trial NCT03669133?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.